Study title
Phase 1, Open Label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn’s Disease and Ulcerative Colitis
Disease or condition
Ulcerative colitis and Crohn’s disease
Study type
Pharmacokinetic study (all receive Ustekinumab)
Intervention/treatment
Ustekinumab
Phase
1
Study site
Duke University
Study location
Durham
Principal investigator
Jane Onken
Study coordinator
Jane Stiles janev.stiles@duke.edu
Phone contact
919-684-1329
Clinicaltrials.gov link
https://clinicaltrials.gov/ct2/show/NCT03358706